FDA — authorised 7 October 2025
- Application: NDA217294
- Marketing authorisation holder: SQ INNOVATION
- Local brand name: LASIX ONYU
- Indication: SOLUTION — SUBCUTANEOUS
- Status: approved
🇺🇸 Lasix ONYU in United States
FDA authorised Lasix ONYU on 7 October 2025
Marketing authorisation
Other Cardiovascular approved in United States
Frequently asked questions
Is Lasix ONYU approved in United States?
Yes. FDA authorised it on 7 October 2025.
Who is the marketing authorisation holder for Lasix ONYU in United States?
SQ INNOVATION holds the US marketing authorisation.